Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 5 (CICP5) is annotated as a pseudogene in the human genome, and specifically related to the capicua transcriptional repressor (CIC) gene. Pseudogenes are gene copies or fragments that typically arise from gene duplication or retrotransposition events and cannot encode a full-length functional protein due to mutations or truncations. CICP5 is catalogued in genetic and genomic databases with aliases such as CICP5, and it shares sequence homology with CIC but is not expressed as a functional protein. Pseudogenes like CICP5 are not considered therapeutic or functional targets, and there is no evidence for its involvement in disease, biological pathways, or drug interaction. If you require information about the *functional* capicua transcriptional repressor (**CIC**), which is involved in transcriptional regulation and has disease relevance, please specify, as this entry pertains strictly to the pseudogene.
None (not a functional target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 5 (CICP5).